Industry
version française
The amending budget will in particular make it possible to promote the development of a European vaccine (photo: European Parliament)
Related articles
-
The European Commission gives the green light to state aid in the field of hydrogen
-
Malta to receive € 817 million from the EU to green and digitalize its economy
-
The European Commission accepts the renewal of a French aid to passenger transport companies
-
The UNCTAD is alarmed by the increase in unemployment and poverty in Palestine
-
European Commission calls for emergency intervention in energy markets
EU. By 643 votes in favour, 29 against and 14 abstentions, the European Parliament adopted, on Thursday 17 September 2020 under the urgent procedure, a proposal to increase the EU budget in 2020 by €6.19 billion in payment appropriations.
This sum will make it possible on the one hand to increase the cohesion funds by €5.1 billion to fight against the crisis caused by the pandemic and on the other hand to devote €1.09 billion to vaccines. On the proposal of the European Commission of 28 August 2020, the European Council had already approved this amending budget (n°8) on 11 September 2020.
The €5.1bn will be used to better guarantee Member States' claims for reimbursement for measures taken in the framework of the Coronavirus Response Investment Initiative Plus (CRII+). This scheme has redirected unspent funds from the EU budget to the fight against the Covid-19 crisis.
The €1.09 billion will therefore go to the Emergency Aid Instrument (EIA) with a significant part of this envelope dedicated to guaranteeing vaccine production in the EU and ensuring sufficient supply in the Member States. The European Commission will thus be able to use these funds as an advance payment for the pre-order of vaccine doses.
This sum will make it possible on the one hand to increase the cohesion funds by €5.1 billion to fight against the crisis caused by the pandemic and on the other hand to devote €1.09 billion to vaccines. On the proposal of the European Commission of 28 August 2020, the European Council had already approved this amending budget (n°8) on 11 September 2020.
The €5.1bn will be used to better guarantee Member States' claims for reimbursement for measures taken in the framework of the Coronavirus Response Investment Initiative Plus (CRII+). This scheme has redirected unspent funds from the EU budget to the fight against the Covid-19 crisis.
The €1.09 billion will therefore go to the Emergency Aid Instrument (EIA) with a significant part of this envelope dedicated to guaranteeing vaccine production in the EU and ensuring sufficient supply in the Member States. The European Commission will thus be able to use these funds as an advance payment for the pre-order of vaccine doses.
